Allogene Therapeutics Inc. (ALLO)
NASDAQ: ALLOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ALLO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $494.05M
- EPS (TTM)
- -$0.66
- Dividend yield
- None
- 52-week range
- 1.04 – 4.46
- Day range
- 1.42 – 1.47
- Volume / Avg
- 3.89M / 5.78M
- Beta
- —
- Shares outstanding
- 345.49M
- Next earnings
- Nov 5, 2026
52-week range
ALLO stock today
Allogene Therapeutics (ALLO) closed at $1.43 on Oct 7, down 2.05% (-$0.03), versus the S&P 500's 0.22% decline. At this level, ALLO sits near the bottom of its 52-week range of $1.04 to $4.46: 67.9% below the high, set on Apr 13, 2026 and 37.5% above the low. ALLO is up 4.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 5.9%.
Allogene Therapeutics has posted a net loss over the last twelve months (EPS of -$0.66), so its P/E ratio is not meaningful. Allogene Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Allogene Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2018
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.13
Allogene Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RGNXREGENXBIO Inc. | 7.60 | +1.95% | $501.37M | vs ALLO |
| AUTLAutolus Therapeutics plc ADR | 1.81 | +1.12% | $481.75M | vs ALLO |
| VALNValneva SE ADR | 5.87 | +0.17% | $556.61M | vs ALLO |
| TECXTectonic Therapeutic Inc. | 22.71 | +1.34% | $443.97M | vs ALLO |
| ENTXEntera Bio Ltd. | 2.51 | -0.79% | $436.32M | vs ALLO |
| ETRAElectra Therapeutics Inc. | 9.16 | -6.72% | $574.95M | vs ALLO |
| AGMBAgomAb Therapeutics NV ADR | 8.80 | -0.45% | $433.38M | vs ALLO |
| EDITEditas Medicine Inc. | 2.75 | +0.73% | $422.35M | vs ALLO |
Indexes, lists and sector
Allogene Therapeutics stock FAQ
What is Allogene Therapeutics's stock price today?
ALLO last traded at $1.43 as of Oct 7, 4:00 PM EDT, down 2.05% on the day. Prices are delayed at least 15 minutes.
When is Allogene Therapeutics's next earnings date?
Allogene Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.13.
What is the ALLO 52-week high?
The 52-week high for ALLO is $4.46 and the 52-week low is $1.04. The stock is currently 67.9% below its high.